These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 19915177

  • 1. Regulation of the ADMA-DDAH system in endothelial cells: a novel mechanism for the sterol response element binding proteins, SREBP1c and -2.
    Ivashchenko CY, Bradley BT, Ao Z, Leiper J, Vallance P, Johns DG.
    Am J Physiol Heart Circ Physiol; 2010 Jan; 298(1):H251-8. PubMed ID: 19915177
    [Abstract] [Full Text] [Related]

  • 2. Adenoviral-mediated overexpression of DDAH improves vascular tone regulation.
    Torondel B, Nandi M, Kelly P, Wojciak-Stothard B, Fleming I, Leiper J.
    Vasc Med; 2010 Jun; 15(3):205-13. PubMed ID: 20219849
    [Abstract] [Full Text] [Related]

  • 3. Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine.
    Hu X, Atzler D, Xu X, Zhang P, Guo H, Lu Z, Fassett J, Schwedhelm E, Böger RH, Bache RJ, Chen Y.
    Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1540-6. PubMed ID: 21493890
    [Abstract] [Full Text] [Related]

  • 4. Protection of DDAH2 overexpression against homocysteine-induced impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells.
    Liu LH, Guo Z, Feng M, Wu ZZ, He ZM, Xiong Y.
    Cell Physiol Biochem; 2012 Jul; 30(6):1413-22. PubMed ID: 23171931
    [Abstract] [Full Text] [Related]

  • 5. Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine.
    Feng M, Liu L, Guo Z, Xiong Y.
    Eur J Pharmacol; 2008 Apr 14; 584(1):49-56. PubMed ID: 18342305
    [Abstract] [Full Text] [Related]

  • 6. Phosphorylation of Nonmuscle Myosin Light Chain Promotes Endothelial Injury in Hyperlipidemic Rats Through a Mechanism Involving Downregulation of Dimethylarginine Dimethylaminohydrolase 2.
    Wu Y, Zhang JJ, Li TB, Liu WQ, Li LS, Luo XJ, Jiang JL, Ma QL, Yang ZC, Peng J.
    J Cardiovasc Pharmacol Ther; 2016 Nov 14; 21(6):536-548. PubMed ID: 26911182
    [Abstract] [Full Text] [Related]

  • 7. Dimethylarginine dimethylaminohydrolase 1 regulates nerve growth factor-promoted differentiation of PC12 cells in a nitric oxide-dependent but asymmetric dimethylargenine-independent manner.
    Wang S, Hu CP, Yuan Q, Zhang WF, Zhou Z, Nie SD, Jiang JL, Li YJ.
    J Neurosci Res; 2012 Jun 14; 90(6):1209-17. PubMed ID: 22488726
    [Abstract] [Full Text] [Related]

  • 8. Correlations of DDAH1 transcript variants with human endothelial asymmetric dimethylarginine metabolizing activity.
    Sun T, Zhou JP, Kuang DB, Li MP, Xiong Y, Tang J, Xia J, Bai YP, Yang GP, Li YJ, Chen XP.
    Am J Hypertens; 2013 Dec 14; 26(12):1437-44. PubMed ID: 23864585
    [Abstract] [Full Text] [Related]

  • 9. Estradiol counteracts oxidized LDL-induced asymmetric dimethylarginine production by cultured human endothelial cells.
    Monsalve E, Oviedo PJ, García-Pérez MA, Tarín JJ, Cano A, Hermenegildo C.
    Cardiovasc Res; 2007 Jan 01; 73(1):66-72. PubMed ID: 17097077
    [Abstract] [Full Text] [Related]

  • 10. Dimethylarginine dimethylaminohydrolase-2 overexpression improves impaired nitric oxide synthesis of endothelial cells induced by glycated protein.
    Lu CW, Xiong Y, He P.
    Nitric Oxide; 2007 Feb 01; 16(1):94-103. PubMed ID: 16979918
    [Abstract] [Full Text] [Related]

  • 11. Inhibitory effect of resveratrol derivative BTM-0512 on high glucose-induced cell senescence involves dimethylaminohydrolase/asymmetric dimethylarginine pathway.
    Yuan Q, Peng J, Liu SY, Wang CJ, Xiang DX, Xiong XM, Hu CP, Li YJ.
    Clin Exp Pharmacol Physiol; 2010 May 01; 37(5-6):630-5. PubMed ID: 20132235
    [Abstract] [Full Text] [Related]

  • 12. Regulation by DDAH/ADMA pathway of lipopolysaccharide-induced tissue factor expression in endothelial cells.
    Xin HY, Jiang DJ, Jia SJ, Song K, Wang GP, Li YJ, Chen FP.
    Thromb Haemost; 2007 May 01; 97(5):830-8. PubMed ID: 17479195
    [Abstract] [Full Text] [Related]

  • 13. 4-HNE increases intracellular ADMA levels in cultured HUVECs: evidence for miR-21-dependent mechanisms.
    Chen L, Zhou JP, Kuang DB, Tang J, Li YJ, Chen XP.
    PLoS One; 2013 May 01; 8(5):e64148. PubMed ID: 23717555
    [Abstract] [Full Text] [Related]

  • 14. Genetic variation in the dimethylarginine dimethylaminohydrolase 1 gene (DDAH1) is related to asymmetric dimethylarginine (ADMA) levels, but not to endothelium-dependent vasodilation.
    Lind L, Ingelsson E, Kumar J, Syvänen AC, Axelsson T, Teerlink T.
    Vasc Med; 2013 Aug 01; 18(4):192-9. PubMed ID: 23892448
    [Abstract] [Full Text] [Related]

  • 15. Protective effect of HDL on endothelial NO production: the role of DDAH/ADMA pathway.
    Peng ZY, Zhao SP, He BM, Peng DQ, Hu M.
    Mol Cell Biochem; 2011 May 01; 351(1-2):243-9. PubMed ID: 21264497
    [Abstract] [Full Text] [Related]

  • 16. Piper sarmentosum Promotes Endothelial Nitric Oxide Production by Reducing Asymmetric Dimethylarginine in Tumor Necrosis Factor-α-Induced Human Umbilical Vein Endothelial Cells.
    Sundar UM, Ugusman A, Chua HK, Latip J, Aminuddin A.
    Front Pharmacol; 2019 May 01; 10():1033. PubMed ID: 31607906
    [Abstract] [Full Text] [Related]

  • 17. Endothelial Dimethylarginine Dimethylaminohydrolase 1 Is an Important Regulator of Angiogenesis but Does Not Regulate Vascular Reactivity or Hemodynamic Homeostasis.
    Dowsett L, Piper S, Slaviero A, Dufton N, Wang Z, Boruc O, Delahaye M, Colman L, Kalk E, Tomlinson J, Birdsey G, Randi AM, Leiper J.
    Circulation; 2015 Jun 23; 131(25):2217-25. PubMed ID: 25910799
    [Abstract] [Full Text] [Related]

  • 18. Tissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocysteinemia.
    Dayal S, Rodionov RN, Arning E, Bottiglieri T, Kimoto M, Murry DJ, Cooke JP, Faraci FM, Lentz SR.
    Am J Physiol Heart Circ Physiol; 2008 Aug 23; 295(2):H816-25. PubMed ID: 18567702
    [Abstract] [Full Text] [Related]

  • 19. cAMP phosphodiesterase inhibitors increases nitric oxide production by modulating dimethylarginine dimethylaminohydrolases.
    Pullamsetti SS, Savai R, Schaefer MB, Wilhelm J, Ghofrani HA, Weissmann N, Schudt C, Fleming I, Mayer K, Leiper J, Seeger W, Grimminger F, Schermuly RT.
    Circulation; 2011 Mar 22; 123(11):1194-204. PubMed ID: 21382892
    [Abstract] [Full Text] [Related]

  • 20. Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is frequently upregulated in prostate cancer, and its overexpression conveys tumor growth and angiogenesis by metabolizing asymmetric dimethylarginine (ADMA).
    Reddy KRK, Dasari C, Duscharla D, Supriya B, Ram NS, Surekha MV, Kumar JM, Ummanni R.
    Angiogenesis; 2018 Feb 22; 21(1):79-94. PubMed ID: 29150732
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.